🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I/Ib trial is to find out the best dose, possible benefits and/o...
Status
Suspended
Location
National Cancer Institute Developmental Therapeutics Clinic
Start Date
2022-02-02
Trial ID
NCT04840589
Vitamin D, beyond its classical role in calcium and phosphate metabolism, i...
Status
Completed
Location
Nooshin Dalili
Start Date
2025-02-01
Trial ID
NCT07409623
Treatments Being Tested
RATIONALE: Diagnostic procedures that analyze surgically-removed tumor tiss...
Status
Completed
Location
University of Chicago Cancer Research Center
Start Date
2002-09
Trial ID
NCT00049010
RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone th...
Status
Terminated
Location
Central Georgia Hematology/Oncology Associates, P.C.
Start Date
2003-11
Trial ID
NCT00611715
Improve knowledge of the immune response to sepsis in obese patients. Defin...
Status
Completed
Location
Ch de Versailles
Start Date
2014-08
Trial ID
NCT02882568
Treatments Being Tested
RATIONALE: Studying samples of tumor tissue and blood from patients with ca...
Status
Completed
Location
Fox Chase Cancer Center - Philadelphia
Start Date
2007-08
Trial ID
NCT00900016
This clinical trial studies gene-modified, human immunodeficiency virus (HI...
Status
Withdrawn
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2016-06-22
Trial ID
NCT02378922
Background: GM1 gangliosidosis is a disorder that destroys nerve cells. It...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-08-19
Trial ID
NCT03952637
Treatments Being Tested
The purposes of this study are to 1) identify the genes responsible for cer...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
1995-06-06
Trial ID
NCT00001467
This phase I trial is studying the side effects and best dose of dovitinib ...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2012-03-29
Trial ID
NCT01497392